Influence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon

Evaluation of vitamin D receptor gene polymorphism and serum 25-hydroxy vitamin d level in patients with hepatocellular carcinoma

Vitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon

Effect of vitamin D supplementation on end treatment response to peginterferon alfa-2b/ribavirin combination in chronic hepatitis c genotype 4

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Single nucleotide polymorphism (SNP) rs8099917 as a predictive factor of virological response to pegylated interferon plus Ribavirin in treatment of chronic hepatitis c virus patients

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Relation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients